BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 35628648)

  • 21. [Relationship between microRNA-155 and hematological malignancies].
    Xue H; Hua LM; Luo JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):810-4. PubMed ID: 23815946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies.
    Dzikiewicz-Krawczyk A
    Crit Rev Oncol Hematol; 2015 Jan; 93(1):1-17. PubMed ID: 25217091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.
    Sevcikova A; Fridrichova I; Nikolaieva N; Kalinkova L; Omelka R; Martiniakova M; Ciernikova S
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA: The Potential Regulator of Endometrial Carcinogenesis.
    Kontomanolis EN; Koukourakis MI
    Microrna; 2015; 4(1):18-25. PubMed ID: 26088599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.
    Weiss CN; Ito K
    Int Rev Cell Mol Biol; 2017; 334():99-175. PubMed ID: 28838543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs and Metabolism: Revisiting the Warburg Effect with Emphasis on Epigenetic Background and Clinical Applications.
    Gaál Z
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double sword role of EZH2 in leukemia.
    Safaei S; Baradaran B; Hagh MF; Alivand MR; Talebi M; Gharibi T; Solali S
    Biomed Pharmacother; 2018 Feb; 98():626-635. PubMed ID: 29289837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting microRNA in hematologic malignancies.
    Han Z; Rosen ST; Querfeld C
    Curr Opin Oncol; 2020 Sep; 32(5):535-544. PubMed ID: 32657797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in benign and malignant hematopoiesis.
    Bhagavathi S; Czader M
    Arch Pathol Lab Med; 2010 Sep; 134(9):1276-81. PubMed ID: 20807046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer.
    Pal A; Ojha A; Ju J
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of microRNAs in the pathogenesis and treatment of hematopoietic malignancies.
    Schmid CA; Craig VJ; Müller A; Flori M
    Curr Pharm Des; 2013; 19(7):1201-10. PubMed ID: 23092340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNAs mediated drug resistance in hematological malignancies.
    Peixoto da Silva S; Caires HR; Bergantim R; Guimarães JE; Vasconcelos MH
    Semin Cancer Biol; 2022 Aug; 83():283-302. PubMed ID: 33757848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA expression profiling in bone marrow: implications in hematological malignancies.
    Costa A; Osório C; Dias S
    Biotechnol J; 2009 Jan; 4(1):88-97. PubMed ID: 19156746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA in carcinogenesis & cancer diagnostics: a new paradigm.
    Ahmad J; Hasnain SE; Siddiqui MA; Ahamed M; Musarrat J; Al-Khedhairy AA
    Indian J Med Res; 2013 Apr; 137(4):680-94. PubMed ID: 23703335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNAs: Key Players in Hematopoiesis.
    Raghuwanshi S; Karnati HK; Sarvothaman S; Gutti U; Saladi RG; Tummala PR; Gutti RK
    Adv Exp Med Biol; 2015; 887():171-211. PubMed ID: 26662992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs in B-cells: from normal differentiation to treatment of malignancies.
    Marques SC; Laursen MB; Bødker JS; Kjeldsen MK; Falgreen S; Schmitz A; Bøgsted M; Johnsen HE; Dybkaer K
    Oncotarget; 2015 Jan; 6(1):7-25. PubMed ID: 25622103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs in Autoimmunity and Hematological Malignancies.
    Di Marco M; Ramassone A; Pagotto S; Anastasiadou E; Veronese A; Visone R
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs in the ontogeny of leukemias and lymphomas.
    Fabbri M; Croce CM; Calin GA
    Leuk Lymphoma; 2009 Feb; 50(2):160-70. PubMed ID: 19160125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs: pivotal regulators in acute myeloid leukemia.
    Li M; Cui X; Guan H
    Ann Hematol; 2020 Mar; 99(3):399-412. PubMed ID: 31932900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.